- Home
- MDGL vs QRVO Comparison
MDGL vs QRVO Comparison
Compare MDGL & QRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- QRVO
- Stock Information
- Founded
- MDGL 2011
- QRVO 1957
- Country
- MDGL United States
- QRVO United States
- Employees
- MDGL N/A
- QRVO N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- QRVO Semiconductors
- Sector
- MDGL Health Care
- QRVO Technology
- Exchange
- MDGL Nasdaq
- QRVO Nasdaq
- Market Cap
- MDGL 6.1B
- QRVO 7.9B
- IPO Year
- MDGL N/A
- QRVO 1997
- Fundamental
- Price
- MDGL $427.96
- QRVO $86.40
- Analyst Decision
- MDGL Strong Buy
- QRVO Hold
- Analyst Count
- MDGL 10
- QRVO 19
- Target Price
- MDGL $474.67
- QRVO $93.83
- AVG Volume (30 Days)
- MDGL 383.6K
- QRVO 1.6M
- Earning Date
- MDGL 10-30-2025
- QRVO 10-28-2025
- Dividend Yield
- MDGL N/A
- QRVO N/A
- EPS Growth
- MDGL N/A
- QRVO N/A
- EPS
- MDGL N/A
- QRVO 0.85
- Revenue
- MDGL $515,547,000.00
- QRVO $3,651,078,000.00
- Revenue This Year
- MDGL $394.12
- QRVO $2.18
- Revenue Next Year
- MDGL $57.74
- QRVO $4.34
- P/E Ratio
- MDGL N/A
- QRVO $102.49
- Revenue Growth
- MDGL 3421.98
- QRVO N/A
- 52 Week Low
- MDGL $200.63
- QRVO $49.46
- 52 Week High
- MDGL $457.16
- QRVO $108.44
- Technical
- Relative Strength Index (RSI)
- MDGL 60.24
- QRVO 38.66
- Support Level
- MDGL $425.00
- QRVO $85.84
- Resistance Level
- MDGL $440.90
- QRVO $93.00
- Average True Range (ATR)
- MDGL 14.19
- QRVO 2.32
- MACD
- MDGL -3.85
- QRVO -0.78
- Stochastic Oscillator
- MDGL 35.07
- QRVO 8.24
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.